Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Gogia

Showing results (1-10 of 179) with videos related to

Pageof 18
Sort By:
Frontiers in Oncology|June 15, 2026
Management of toxicities from antibody - drug conjugates in breast cancerAjay Gogia
The New England Journal of Medicine|July 14, 2021
Sacituzumab Govitecan in Metastatic Breast CancerShuvadeep Ganguly, Ajay Gogia
The New England Journal of Medicine|September 2, 2022
PD-1 Blockade in Mismatch Repair-Deficient Rectal CancerShuvadeep Ganguly, Ajay Gogia
The Lancet. Oncology|December 1, 2022
Pembrolizumab as adjuvant therapy in non-small-cell lung cancerShuvadeep Ganguly, Ajay Gogia
The Indian Journal of Medical Research|March 29, 2022
Cutaneous T-cell lymphomaShalabh Arora, Ajay Gogia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast CancerNithin Sg, Ajay Gogia
The Lancet. Oncology|June 4, 2021
Pembrolizumab monotherapy in advanced triple-negative breast cancerShuvadeep Ganguly, Ajay Gogia
The New England Journal of Medicine|May 4, 2022
Pembrolizumab in Early Triple-Negative Breast CancerShuvadeep Ganguly, Ajay Gogia
The National Medical Journal of India|July 2, 2021
Adding ovarian suppression to tamoxifen for pre-menopausal breast cancerAbhenil Mittal, Ajay Gogia
JAMA Oncology|June 30, 2022
Capecitabine Maintenance in Metastatic Nasopharyngeal CarcinomaShuvadeep Ganguly, Ajay Gogia
Pageof 18

Showing results (1-10 of 179) with videos related to

Sort By:
Pageof 18
Frontiers in Oncology|June 15, 2026
Management of toxicities from antibody - drug conjugates in breast cancerAjay Gogia
The New England Journal of Medicine|July 14, 2021
Sacituzumab Govitecan in Metastatic Breast CancerShuvadeep Ganguly, Ajay Gogia
The New England Journal of Medicine|September 2, 2022
PD-1 Blockade in Mismatch Repair-Deficient Rectal CancerShuvadeep Ganguly, Ajay Gogia
The Lancet. Oncology|December 1, 2022
Pembrolizumab as adjuvant therapy in non-small-cell lung cancerShuvadeep Ganguly, Ajay Gogia
The Indian Journal of Medical Research|March 29, 2022
Cutaneous T-cell lymphomaShalabh Arora, Ajay Gogia
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 6, 2023
Sacituzumab Govitecan in Hormone Receptor-Positive Metastatic Breast CancerNithin Sg, Ajay Gogia
The Lancet. Oncology|June 4, 2021
Pembrolizumab monotherapy in advanced triple-negative breast cancerShuvadeep Ganguly, Ajay Gogia
The New England Journal of Medicine|May 4, 2022
Pembrolizumab in Early Triple-Negative Breast CancerShuvadeep Ganguly, Ajay Gogia
The National Medical Journal of India|July 2, 2021
Adding ovarian suppression to tamoxifen for pre-menopausal breast cancerAbhenil Mittal, Ajay Gogia
JAMA Oncology|June 30, 2022
Capecitabine Maintenance in Metastatic Nasopharyngeal CarcinomaShuvadeep Ganguly, Ajay Gogia
Pageof 18